Australia Biotechnology & Medical Research

Arovella Therapeutics Ltd (ALA)

No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Gary Phillips Director
Transaction date
Planned purchase
Price
142.57
Quantity 64,586
Value A$2,984,270
Michael Baker Director
Transaction date
Planned purchase
Price
207.11
Quantity 87,086
Value A$2,809,832
Thomas Duthy Director
Transaction date
Planned purchase
Price
451.76
Quantity 1,045
Value A$1,880,943
Michael Baker Director
Transaction date
Purchase
Price
0.02
Quantity 1,250,000
Value A$25,000
Gary Phillips Director
Transaction date
Purchase
Price
0.02
Quantity 500,000
Value A$10,000
Elizabeth Stoner Director
Transaction date
Purchase
Price
0.02
Quantity 500,000
Value A$10,000
Michael Baker Director
Transaction date
Purchase
Price
0.04
Quantity 1,586,842
Value A$60,300
Elizabeth Stoner Director
Transaction date
Purchase
Price
0.04
Quantity 263,157
Value A$10,000
Debora Barton Director
Transaction date
Purchase
Price
0.04
Quantity 263,157
Value A$10,000
David Simmonds Director
Transaction date
Purchase
Price
0.04
Quantity 263,157
Value A$10,000
Michael Baker Director
Transaction date
Purchase
Price
0.04
Quantity 789,473
Value A$30,000
Paul Hopper Director
Transaction date
Purchase
Price
0.04
Quantity 3,894,734
Value A$148,000
Paul Hopper Director
Transaction date
Purchase
Price
0.04
Quantity 555,556
Value A$20,000
David Tudor Phillips Director
Transaction date
Purchase
Price
0.04
Quantity 138,889
Value A$5,000
Michael Baker Director
Transaction date
Purchase
Price
0.04
Quantity 416,667
Value A$15,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-07-12 2023-07-12 PP Planned purchase Gary Phillips Director
64,586
142.57
A$2,984,270 		64,586 142.57 A$2,984,270
2023-07-12 2023-07-12 PP Planned purchase Michael Baker Director
87,086
207.11
A$2,809,832 		87,086 207.11 A$2,809,832
2023-07-12 2023-07-12 PP Planned purchase Thomas Duthy Director
1,045
451.76
A$1,880,943 		1,045 451.76 A$1,880,943
2023-05-05 2023-05-05 B Purchase Michael Baker Director
1,250,000
0.02
A$25,000 		1,250,000 0.02 A$25,000
2023-05-05 2023-05-05 B Purchase Gary Phillips Director
500,000
0.02
A$10,000 		500,000 0.02 A$10,000
2023-05-05 2023-05-05 B Purchase Elizabeth Stoner Director
500,000
0.02
A$10,000 		500,000 0.02 A$10,000
2022-12-05 2022-12-02 B Purchase Michael Baker Director
1,586,842
0.04
A$60,300 		1,586,842 0.04 A$60,300
2022-03-16 2022-03-16 B Purchase Elizabeth Stoner Director
263,157
0.04
A$10,000 		263,157 0.04 A$10,000
2022-03-16 2022-03-16 B Purchase Debora Barton Director
263,157
0.04
A$10,000 		263,157 0.04 A$10,000
2022-03-16 2022-03-16 B Purchase David Simmonds Director
263,157
0.04
A$10,000 		263,157 0.04 A$10,000
2022-03-16 2022-03-16 B Purchase Michael Baker Director
789,473
0.04
A$30,000 		789,473 0.04 A$30,000
2022-03-16 2022-03-16 B Purchase Paul Hopper Director
3,894,734
0.04
A$148,000 		3,894,734 0.04 A$148,000
2021-02-16 2021-02-16 B Purchase Paul Hopper Director
555,556
0.04
A$20,000 		555,556 0.04 A$20,000
2021-02-16 2021-02-16 B Purchase David Tudor Phillips Director
138,889
0.04
A$5,000 		138,889 0.04 A$5,000
2021-02-16 2020-02-16 B Purchase Michael Baker Director
416,667
0.04
A$15,000 		416,667 0.04 A$15,000
Explore more

More insider trading research around Arovella Therapeutics Ltd

More insider trades in Australia
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Asia-Pacific